Intravenous Immunoglobulin Market by Component (IgG, IgA, IgM, IgE, and IgD), by Application (Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura, Hypogammaglobulinemia, Multifocal Motor Neuropathy, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), and by End-User (Hospitals, Clinics, and Homecare Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 30-Jul-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-2934
Status : Published
Global intravenous immunoglobulin market expected to generate around USD 16.42 billion by 2025, at a CAGR of around 7.6% between 2019 and 2025. Immunoglobulins are glycoproteins that are often produced in the blood plasma, which respond to antigens present in the body.